Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells

Circulation

Volumn 102, Issue 20, 2000, Pages 2522-2527

  Ito, Takayuki ^a   Ikeda, Uichi ^a   Shimpo, Masahisa ^a   Yamamoto, Keiji ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Interleukins; Muscle, smooth; Thrombosis

Indexed keywords

ALPHA METHYLSEROTONIN; CALPHOSTIN C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KETANSERIN; KT 5720; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; SARPOGRELATE; SEROTONIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034649327     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.20.2522     Document Type: Article

References (50)

1. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
2. Dual control of CRP gene expression by interleukin-1 and interleukin-6
3. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
4. 2-Macroglobulin synthesis in interleukin-6 stimulated human neuronal (SH-SY5Y neuroblastoma) cells: Potential significance for the processing of Alzheimer β-amyloid precursor protein
5. Lipoprotein(a) and lipoprotein profile in healthy centenarians: A reappraisal of vascular risk factors
6. Serum interleukin 6 levels become elevated in acute myocardial infarction
7. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation
8. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
9. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions
10. Expression of interleukin-6 in atherosclerotic lesions of male apo E-knockout mice inhibition of 17β-estradiol
11. Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits
12. Inhibitory effect of interleukin 6 on vascular smooth muscle contraction
13. Interleukin-6 stimulates the growth of vascular cells in a PDGF-dependent manner
14. Interleukin-6 induces the expression of vascular endothelial growth factor
15. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line
16. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease
17. Effect of serotonin and 5-hydroxy-indole-3-acetic acid on smooth muscle cell proliferation
18. 2+ channels and phospholipase C
19. Serotonin stimulated the expression of thrombin receptors in cultured vascular smooth muscle cells
20. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries
21. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries
22. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury
23. Serotonin-stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factor
24. Transcardiac serotonin concentration is increased in selected patients with limiting and complex coronary lesion morphology
25. Specific platelet mediators and unstable coronary artery lesions: Experimental evidence and potential clinical implications
26. Local effect of serotonin released during coronary angioplasty
27. 2 receptor sites
28. Expression of serotonin receptor mRNAs in blood vessels
29. 2 receptor subtype in human coronary arteries
30. Characterization of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques
31. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: Inhibition by ketanserin
32. Serotonin-stimulated protein phosphorylation in aortic smooth muscle cells
33. Effect of 5-hydroxytryptamine on intracellular calcium dynamics in cultured rat vascular smooth muscle cells
34. 2+ channels associated with protein kinase C activity
35. Activation of protein kinase C isozymes by contractile stimuli in arterial smooth muscle
36. Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1
37. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976
38. Activation of interleukin-6 gene expression through the NF-κB transcription factor
39. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion
40. The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth-muscle cells in vitro and human atherosclerosis
41. Function and activation of NF-κB in the immune system
42. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation
43. Serotonin is associated with coronary artery disease and cardiac events
44. Intracoronary serotonin release after high-pressure coronary stenting
45. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque
46. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries
47. Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction
48. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
49. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
50. Interleukin-6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis